Influenza A/H1N1 Vaccine in Patients Treated by Kidney Transplant or Dialysis

Abstract

The influenza A/H1N1-adjuvanted vaccine is of limited efficacy but is safe in renal disease populations. The humoral response is lower in transplanted versus hemodialyzed patients. Further studies are needed to improve the efficacy of vaccination in those populations.